Equity Capital: 460.34 Cr FV: 10.00
| Period | MF Net Purchase / (sold) | FII Net |
|---|---|---|
| LAST 1M | 16,852.71 | -20,671.82 |
| LAST 3M | 52,922.55 | -3,405.64 |
| LAST 6M | 58,662.39 | 139,660.95 |
| LAST 12M | 135,235.34 | 165,245.59 |
| Date | Action Type | Ratio |
|---|---|---|
| No data found |
Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as `WHO-GMP` as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc. In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and Detox.
S C No 857 Cabin No 10 2nd Flr, N A C Manimajra, Chandigarh, Chandigarh, 160101
| : | investorgrievance:venusremedies.co.in | |
| Website | : | http://www.venusremedies.com |
Link Intime India Pvt Ltd
| AGM Date (Month) | : | Aug |
| Face Value Equity Shares | : | 10 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 526953 |
| NSE Code | : | VENUSREM |
| Book Closure Date (Month) | : | |
| BSE Group | : | T |
| ISIN | : | INE411B01019 |
FAQ’s on Venus Remedies Ltd SharesYou can buy Venus Remedies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Venus Remedies Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Oct 03, 2023 03:45 PM the closing price of Venus Remedies Ltd was ₹ 248.10.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Oct 03, 2023 03:45 PM, the market cap of Venus Remedies Ltd stood at ₹ 331.64.
The latest PE ratio of Venus Remedies Ltd as of Oct 03, 2023 03:45 PM is 16.22
The latest PB ratio of Venus Remedies Ltd as of Oct 03, 2023 03:45 PM is 1.39
The 52-week high of Venus Remedies Ltd is ₹ 300.00 while the 52-week low is ₹ 145.80
Download Our App
Invest
